Farms.com Home   News

CGC Determines $3.7 Million Owed To Eligible Producers

The Canadian Grain Commission reports all eligible producers who were not paid for grain delivered to Canpulse Foods Ltd. and Global Grain Canada Ltd. will be fully compensated through the CGC's Safeguards for Grain Farmers Program.
 
The CGC had suspended the licences of Canpulse Foods, Global Grain Canada and their parent company Globeways Canada Inc. on October 31, 2020 after it was determined they could not provide security as outlined in their licence.
 
The companies were then placed into receivership and producers owed money for deliveries were able to file claims with the CGC.
 
After a review of individual producer claims, it was determined that there were 40 eligible claims involving Canpulse Foods Ltd. totalling over $3 million and 13 eligible claims for Global Grain Canada Ltd worth about $700,000.
 
All eligible claims are fully covered by the security posted by Canpulse Foods Ltd. and Global Grain Canada Ltd.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.